Not available
Quote | Pulse Biosciences Inc (NASDAQ:PLSE)
Last: | $6.77 |
---|---|
Change Percent: | -1.31% |
Open: | $6.92 |
Close: | $6.86 |
High: | $6.935 |
Low: | $6.67 |
Volume: | 67,806 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
News | Pulse Biosciences Inc (NASDAQ:PLSE)
2024-04-04 10:00:40 ET More on Pulse Biosciences Pulse Biosciences Inc (PLSE) Q4 2023 Earnings Call Transcript Pulse Biosciences to initiate rights offering Financial information for Pulse Biosciences Read the full article on Seeking Alpha For further...
2024-04-01 10:00:18 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Eli ...
Message Board Posts | Pulse Biosciences Inc (NASDAQ:PLSE)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $PLSE News Article - Pulse Biosciences, Inc. Appoints Dr. Gan Dunnington as Chief Medic | whytestocks | investorshangout | 05/03/2023 3:50:46 PM |
Found an interesting article | Philmasta | investorshub | 04/30/2023 3:54:05 PM |
Long and strong lets hope im right | whizknock | investorshub | 04/30/2023 3:17:57 PM |
$PLSE we got news | Converter | investorshub | 04/30/2023 3:14:14 PM |
$PLSE Thoughts on where this is headed? | TheFinalCD | investorshub | 04/28/2023 7:29:16 PM |
News, Short Squeeze, Breakout and More Instantly...
Pulse Biosciences Inc Company Name:
PLSE Stock Symbol:
NASDAQ Market:
Pulse Biosciences Inc Website:
Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expected fourth-quar...
With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street ex...
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced business updates and financial results for the fourth quarter and full year ended December 31, 2023. Recen...